• Jefferson D Revell, Per-Eric Lund, John E Linley, Jacky Metcalfe, Nicole Burmeister, Sudharsan Sridharan, Clare Jones, Lutz Jermutus, and Maria A Bednarek.
• MedImmune, Cambridge, United Kingdom. revellj@medimmune.com
• Peptides. 2013 Jun 1; 44: 40-6.

AbstractThe spider venom peptide Huwentoxin-IV (HwTx-IV) 1 is a potent antagonist of hNav1.7 (IC50 determined herein as 17 ± 2 nM). Nav1.7 is a voltage-gated sodium channel involved in the generation and conduction of neuropathic and nociceptive pain signals. We prepared a number of HwTx-IV analogs as part of a structure-function study into Nav1.7 antagonism. The inhibitory potency of these analogs was determined by automated electrophysiology and is reported herein. In particular, the native residues Glu(1), Glu(4), Phe(6) and Tyr(33) were revealed as important activity modulators and several peptides bearing mutations in these positions showed significantly increased potency on hNav1.7 while maintaining the original selectivity profile of the wild-type peptide 1 on hNav1.5. Peptide 47 (Gly(1), Gly(4), Trp(33)-HwTx) demonstrated the largest potency increase on hNav1.7 (IC50 0.4 ± 0.1 nM).Copyright © 2013 Elsevier Inc. All rights reserved.

24 keywords...

hide…